Discover groundbreaking research showing that lungs, alongside bone marrow, play a crucial role in blood cell production, ...

The firm's Qlucore Diagnostics 1.0 for BCP-ALL software is used to aid the diagnosis and treatment of B-cell precursor acute lymphoblastic leukemia.

Dr Vivek Verma, Associate Director-Surgical Oncology, Max Super Speciality Hospital Patparganj highlights that pediatric ...

A panel of 10 expert hematologists created recommendations for optimal MRD-guided ALL treatment, which were recently ...

Precigen's PRGN-2012 and UltraCAR-Ts offer groundbreaking therapies. Read why PGEN stock is a strong pick, with major ...

Dr Nitin Sood, Senior Director-Medical Oncology, Bone Marrow Transplant, Cancer Care, Medanta, Gurugram explains how AI and ...

Updated data show AYVAKIT® (avapritinib) was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life benefit and no new safety signals with multiple years of ...

LAVA Therapeutics reviews strategic options amid cost cuts. HC Wainwright downgrades stock, citing uncertainties over LAVA-1266 and possible business shifts.

Nuvalent, Inc. , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., ...

The Vici grant is one of the largest personal scientific grants in the Netherlands, and, according to NWO, intended for ‘senior researchers with academic qualities that clearly exceed what is usual’.

It took nearly three years to win presumptive workers' compensation coverage for breast, cervical, and other cancers that firefighters who work for federal agencies may develop because of hazardous ...